Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis-Reference-Cited by-同舟云学术

Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis

Published:1993-08 Issue:4 Volume:84 Page:662-669
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Tartary Michel,Vidaud Dominique,Piao Yingchao,Costa Jean-Marc,Bahnak Bruce R.,Fressinaud Edith,Congard Brigitte,Laurian Yves,Meyer Dominique,Lavergne Jean-Maurice,Vidaud Michel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1993.tb03143.x/fullpdf

Reference30 articles.

1. Mutations in the catalytic domain of human coagulation factor IX: Rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior

2. Carrier Detection in Severe (Type III) von Willebrand Disease Using Two Intragenic Restriction Fragment Length Polymorphisms

3. The three-dimensional structure of the first EGF-like module of human factor IX: Comparison with EGF and TGF-α

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanism of a novel Ser362Asn mutation causing inherited FX deficiency in a Chinese family;International Journal of Hematology;2020-04-13

2. Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice;Thrombosis and Haemostasis;2019-10-28

3. A new in silico approach to investigate molecular aspects of factor IX missense causative mutations and their impact on the hemophilia B severity;Human Mutation;2019-03-28

4. Biopharmaceuticals: Post‐Translational Modification Carboxylation and Hydroxylation;Post‐translational Modification of Protein Biopharmaceuticals;2009-04-15

5. Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B;Clinical Genetics;2008-06-28